Sort
326,823 grants matching “clinical trial”
Improved Anthrax Vaccine Stability & use of Adjuvants
$2,999,760Allan Watkinson · Avecia Biologics, Ltd · UC1 · FY2007 · AI
Statin Treatment and Incident Alzheimer's Disease and Related Dementias in a Large, Multi-ethnic Health Plan
$2,999,547Catherine Ann Schaefer · Kaiser Foundation Research Institute · RF1 · FY2020 · AG
Targeted DOK7 gene therapy for Congenital Myasthenic Syndromes
$2,999,358Patricio Sepulveda · Amplo Biotechnology, Inc. · R44 · FY2024 · NS
Participant Engagement Unit
$2,999,293Elizabeth B. Claus · Yale University · U2C · FY2021 · CA
CLINICAL PHARMACOKINETICS AND SAFETY TRIALS IN DOWN SYNDROME
$2,999,168Mara Becker · Duke University · N01 · FY2019 · HD
Center for Integrated Biomedical and Rural Health Research
$2,999,138Renee A Reijo Pera · Mc Laughlin Research Institute · P20 · FY2024 · GM
Stanford University Cancer Center
$2,998,871Beverly Shriver Mitchell · Stanford University · P30 · FY2014 · CA
Treatment of Peanut Allergy with Intradermal Administration of ASP0892 (ARA-LAMP-vax): A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Study
$2,998,654Robert A Wood · Johns Hopkins University · UM2 · FY2022 · AI
OHSU Knight Cancer Institute
$2,998,501Brian J Druker · Oregon Health & Science University · P30 · FY2009 · CA
Novel Medication Approaches for Substance Abuse
$2,998,246Herbert David Kleber · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · P50 · FY2008 · DA
MIND Diet Intervention to Prevent Alzheimer's Disease
$2,997,666Martha C. Morris · Rush University Medical Center · R01 · FY2017 · AG
2/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
$2,997,389Thomas Scott Stroup · Columbia University Health Sciences · R01 · FY2011 · MH
Protective immunity following dengue virus natural infections and vaccination
$2,996,634Eva Harris · University Of California Berkeley · P01 · FY2016 · AI
Development of a Next Generation Vaccine for Smoking Cessation and Relapse Preven
$2,996,608Lloyd Patrick Johnston · Selecta Biosciences, Inc. · RC3 · FY2010 · DA
Immunobiology and Immune Therapy for Merkel Cell Carcinoma
$2,996,200Paul Nghiem · University Of Washington · P01 · FY2020 · CA
Novel antibacterial agents for treatment of Tularemia
$2,995,855Affinium Pharmaceuticals, Inc. · U01 · FY2004 · AI
Preclinical development and translation
$2,995,716Annette Reingart Von Delft · Sloan-Kettering Inst Can Research · U19 · FY2022 · AI
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION
$2,995,175James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2012 · AI
Clinical Testing of an Intracortical Visual Prosthesis System
$2,995,047Philip R. Troyk · Illinois Institute Of Technology · UG3 · FY2016 · NS
Immunobiology and Immune Therapy for Merkel Cell Carcinoma
$2,994,993Paul Nghiem · University Of Washington · P01 · FY2025 · CA
Children's Oncology Group Chair's Grant
$2,994,733Gregory H Reaman · National Childhood Cancer Foundation · U10 · FY2006 · CA
Statistical and Data Coordinating Center: SARS-CoV-2/COVID-19 Studies
$2,994,239Marian Ewell · The Emmes Company, Llc · N01 · FY2021 · AI
Cancer Center Support Grant - P30
$2,993,642Ralph W. De Vere White · University Of California At Davis · P30 · FY2010 · CA
Assay Development and High Throughput Screening (ADHTS) Core
$2,993,464Jeffrey Dage · Indiana University Indianapolis · U54 · FY2025 · AG
Administrative Core
$2,993,432Drew Memmott · Dana-Farber Cancer Inst · P30 · FY2017 · CA